{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:15:35Z","timestamp":1773551735167,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.aace.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:00:38Z","timestamp":1704992438000},"page":"60-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Van","family":"Phan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John","family":"Aurora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma","family":"Gondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-3640","authenticated-orcid":false,"given":"Lisa","family":"Ceglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10344","key":"10.1016\/j.aace.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","article-title":"Coeliac disease","volume":"399","author":"Catassi","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.aace.2024.01.001_bib2","first-page":"201","article-title":"Hypocalciuria and abnormalities in mineral and skeletal homeostasis in patients with celiac sprue without intestinal symptoms","volume":"4","author":"Ott","year":"1997","journal-title":"Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.aace.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"Van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.aace.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bone.2003.11.026","article-title":"Perspectives on glucocorticoid-induced osteoporosis","volume":"34","author":"Canalis","year":"2004","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.aace.2024.01.001_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/js.2018-00118","article-title":"Osteoanabolic agents for osteoporosis","volume":"2","author":"Haas","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"issue":"20","key":"10.1016\/j.aace.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.aace.2024.01.001_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267706","article-title":"The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: a meta-analysis and systematic review of randomized controlled trials","volume":"17","author":"Liu","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.aace.2024.01.001_bib8","doi-asserted-by":"crossref","first-page":"e4222","DOI":"10.1210\/clinem\/dgac486","article-title":"Abaloparatide increases lumbar spine and hip BMD in Japanese patients with osteoporosis: the Phase 3 ACTIVE-J Study","volume":"107","author":"Matsumoto","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.aace.2024.01.001_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.aace.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/jbmr.1999.14.4.652","article-title":"Bone loss in celiac disease is related to secondary hyperparathyroidism","volume":"14","author":"Selby","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.aace.2024.01.001_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13643-021-01772-9","article-title":"Gluten in pharmaceutical products: a scoping review","volume":"10","author":"Lizano-D\u00edez","year":"2021","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.aace.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.5688\/ajpe6353","article-title":"Exploring the community pharmacist\u2019s knowledge of celiac disease","volume":"82","author":"Avena-Woods","year":"2018","journal-title":"Am J Pharm Educ"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T08:15:35Z","timestamp":1710749735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060524000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2376060524000014"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2024.01.001","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}